Clinical Trials Browser

Completed × Observational × pembrolizumab × Clear all

NCT06345183 2025-11-06

Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients

Advanced Renal Cell Carcinoma (aRCC)

NCT06771674 2025-09-09

Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT07015333 2025-06-11

Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

Squamous Cell Carcinoma of Head and Neck

NCT05834348 2025-03-30

DELINOR

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT02791594 2024-11-08

Imaging FDG Flare in Melanoma

21 enrolled 10 charts

Melanoma

NCT06607393 2024-09-23

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT06585189 2024-09-05

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02600169 2024-05-06

Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab

Melanoma

NCT04627012 2024-03-06

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT05908799 2023-09-13

Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT05611229 2023-04-06

Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden

Melanoma

NCT02909348 2023-03-02

PASIP

Melanoma, Neoplasms

NCT03453892 2023-02-16

ST-ICI

Neoplasm Metastasis

NCT03197636 2022-03-03

Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Melanoma

NCT05023837 2022-01-25

Esporta

Uncommon Pathological Types of Lung Cancer

NCT03695835 2020-07-22

NIRPA

GastrointestinalGenitourinaryThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms